ArticleBMJ public health2026
Are menopausal and andropausal symptoms associated with presenteeism? A cross-sectional survey of white-collar employees at 14 large corporations in Tokyo, Japan.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the association of menopausal and andropausal symptom severity with presenteeism among working Japanese adults. Methods: A cross-sectional survey of 3063 employees (1912 men aged ≥30 years and 1151 women aged ≥40 years) from 14 corporations headquartered in Tokyo's Marunouchi District was conducted. Menopausal (women) and andropausal (men) symptoms were assessed using the Simplified Menopausal Index and Aging Male Symptom scale, respectively. Respondents recalled and reported the number of presenteeism days within the past month. Mixed-effects negative binomial regression was used to evaluate the association between menopausal and andropausal symptom severity and the risk of presenteeism, adjusting for sociodemographic, lifestyle and employment-related factors. Results: Among women aged ≥40 years, 28% reported moderate-to-severe menopausal symptoms, while 27.5% of men aged ≥30 years reported moderate-to-severe andropausal symptoms. Women with menopausal symptoms requiring treatment and those with severe symptoms had significantly higher risks of presenteeism than those without symptoms, with adjusted relative risks of 2.47 (95% CI 1.76 to 3.45) and 2.98 (95% CI 1.74 to 5.11), respectively. Men with severe andropausal symptoms had a 3.55-fold higher risk (95% CI 2.65 to 4.74) of experiencing presenteeism than those without symptoms. These associations remained robust among women and men even after excluding participants with psychological distress. Conclusions: Higher menopausal and andropausal symptom severity was significantly associated with an increased risk of presenteeism among working Japanese adults. Inclusive workplace health policies acknowledging these symptoms as critical factors influencing presenteeism, organisational well-being and sex equity are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.